These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1850095)

  • 1. Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.
    Engler DA; Hauser MR; Cook JS; Niyogi SK
    Mol Cell Biol; 1991 May; 11(5):2425-31. PubMed ID: 1850095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
    Tadaki DK; Niyogi SK
    J Biol Chem; 1993 May; 268(14):10114-9. PubMed ID: 8486681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor.
    van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ
    J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-binding affinities of human epidermal growth factor variants having unnatural amino acid residues in position 23.
    Koide H; Yokoyama S; Katayama Y; Muto Y; Kigawa T; Kohno T; Takusari H; Oishi M; Takahashi S; Tsukumo K
    Biochemistry; 1994 Jun; 33(23):7470-6. PubMed ID: 8003512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.
    Engler DA; Campion SR; Hauser MR; Cook JS; Niyogi SK
    J Biol Chem; 1992 Feb; 267(4):2274-81. PubMed ID: 1733935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.
    Engler DA; Montelione GT; Niyogi SK
    FEBS Lett; 1990 Oct; 271(1-2):47-50. PubMed ID: 2172006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32.
    Koide H; Muto Y; Kasai H; Hoshi K; Takusari H; Kohri K; Takahashi S; Sasaki T; Tsukumo K; Miyake T
    FEBS Lett; 1992 May; 302(1):39-42. PubMed ID: 1587350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of authentic human epidermal growth factor as a bacterial secretory protein and its initial structure-function analysis by site-directed mutagenesis.
    Engler DA; Matsunami RK; Campion SR; Stringer CD; Stevens A; Niyogi SK
    J Biol Chem; 1988 Sep; 263(25):12384-90. PubMed ID: 3045117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.
    Campion SR; Geck MK; Niyogi SK
    J Biol Chem; 1993 Jan; 268(3):1742-8. PubMed ID: 8380576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
    Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
    Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor recognition by histidine 16 of human epidermal growth factor via hydrogen-bond donor/acceptor interactions.
    Nandagopal K; Terzaghi-Howe M; Niyogi SK
    J Cell Biochem; 1999 Jan; 72(1):16-24. PubMed ID: 10025663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional importance of Leu15 of human epidermal growth factor in receptor binding and activation.
    Nandagopal K; Tadaki DK; Lamerdin JA; Serpersu EH; Niyogi SK
    Protein Eng; 1996 Sep; 9(9):781-8. PubMed ID: 8888144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation.
    Countaway JL; McQuilkin P; Gironès N; Davis RJ
    J Biol Chem; 1990 Feb; 265(6):3407-16. PubMed ID: 2105948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity.
    van de Poll ML; van Vugt MJ; Lenferink AE; van Zoelen EJ
    Biochemistry; 1997 Jun; 36(24):7425-31. PubMed ID: 9200690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity.
    Simpson RJ; Smith JA; Moritz RL; O'Hare MJ; Rudland PS; Morrison JR; Lloyd CJ; Grego B; Burgess AW; Nice EC
    Eur J Biochem; 1985 Dec; 153(3):629-37. PubMed ID: 3000782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor.
    Gotoh N; Tojo A; Hino M; Yazaki Y; Shibuya M
    Biochem Biophys Res Commun; 1992 Jul; 186(2):768-74. PubMed ID: 1323290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.
    Wu DG; Wang LH; Sato GH; West KA; Harris WR; Crabb JW; Sato JD
    J Biol Chem; 1989 Oct; 264(29):17469-75. PubMed ID: 2477372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.